Mustang Bio Inc reports results for the quarter ended in March - Earnings Summary

Mustang Bio

15/05/2021 04:55

* Mustang Bio Inc  MBIO.OQ  reported a quarterly adjusted loss
of 19 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 19 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Mustang Bio Inc's reported EPS for the quarter was a loss
of 19 cents​.
* The mean earnings estimate of analysts had risen by
about 11.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Mustang Bio Inc shares had fallen by 18.7% this quarter and
lost 28.7% so far this year.
* The company reported a quarterly loss of $14.96 million.
* Wall Street's median 12-month price target for Mustang Bio Inc
is $10.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 15 at 03:55 a.m. GMT.
​All figures in US dollars